Physician

Tomasz P Stys, M.D.

According to 2025 Medicare claims, Tomasz Stys, M.D. (NPI: 1891790978) practices interventional cardiology in the Sioux Falls, SD-MN market, with the plurality of this provider's patient population coming from Minnehaha, SD. This provider's primary affiliated billing organization is SANFORD MEDICAL CENTER (NPI: 1093090342; TIN: 460227855) and primary practice location at 57105-0401. Stys is affiliated with the Prairie Vista Care Organization (ACO ID: A3578), Avera Prairie View ACO (ACO ID: A4692), Caravan Health ACO 43 LLC (ACO ID: A4974), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Stys' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,436 traditional Medicare patients, billed 9,813 HCPCS/CPT codes, and received $538,091 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 9,708 prescription claims across 1,799 beneficiaries totaling $1,400,650 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 15 claims. Open Payments data shows 56 records totaling $56,584. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $107,228 to $1,400,650. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $20,835 to $35,446.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,707	6,740	$452,626
2016	1,819	7,069	$472,595
2017	1,847	7,882	$531,479
2018	2,049	8,836	$562,220
2019	2,032	9,034	$594,800
2020	2,116	7,994	$526,575
2021	2,237	9,488	$580,147
2022	2,116	9,246	$556,029
2023	2,254	9,055	$540,718
2024	2,436	9,813	$538,091

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	805	3,964	$107,228
2016	820	4,445	$148,779
2017	937	4,737	$259,595
2018	1,106	5,573	$375,456
2019	1,229	6,345	$468,148
2020	1,305	7,022	$652,158
2021	1,278	6,884	$849,413
2022	1,319	6,627	$1,004,402
2023	1,564	8,538	$1,176,816
2024	1,799	9,708	$1,400,650

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	22	$46,467
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	14	$31,265
2023	N/R	15	$35,446
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,158	1,381	$64
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	1,232	1,330	$49
93016	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician	566	571	$15
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	563	569	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	790	940	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	916	44,836	$846,107
Repatha Sureclick	Evolocumab	236	7,619	$145,958
Xarelto	Rivaroxaban	158	7,557	$133,736
Brilinta	Ticagrelor	191	5,860	$84,669
Praluent Pen	Alirocumab	102	3,248	$55,286

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$791	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	25	$55,793	Abbott Laboratories
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tomasz P. Stys, M.D.?

Tedicare shows public-source Medicare data for Tomasz P. Stys, M.D. (NPI 1891790978), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tomasz P. Stys, M.D. have ACO affiliation data?

Tomasz P. Stys, M.D. is shown with ACO affiliation data for Prairie Vista Care Organization (MSSP, ACO ID A3578), Avera Prairie View ACO (MSSP, ACO ID A4692), Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Tomasz P. Stys, M.D.?

Tomasz P. Stys, M.D. is linked to SANFORD MEDICAL CENTER (billing NPI 1093090342) in the available physician profile data.

Does Tomasz P. Stys, M.D. have Open Payments data?

Tomasz P. Stys, M.D. has 56 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.